Thomas Daubon

Thomas Daubon is a CNRS Research Director (DR2) and group leader at CNRS UMR5095, where they oversee the GBmetabo team specializing in glioblastoma metabolism and its interactions with various cell types. They have held several research positions, including post-doctoral roles at INSERM and a junior research scientist position in the Department of Biomedicine. Daubon earned a Research Doctorate in Oncology and Cancer Biology with distinction from Université de Poitiers and a Master's degree in the same field from Université Paul Sabatier. Their current work focuses on understanding metabolic adaptations in glioblastoma in response to challenges in development and treatment.